🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to determine the safety and efficacy o...
Status
Unknown
Location
The Affiliated People's Hospital of Ningbo University
Start Date
2021-09-16
Trial ID
NCT05528887
Treatments Being Tested
This research study is being carried out to study a new way to possibly tre...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2019-07-31
Trial ID
NCT03617198
Treatments Being Tested
This clinical study is to investigate the safety and tolerability of CAR mo...
Status
Terminated
Location
Shanghai Zhongshan Hospital
Start Date
2019-05-16
Trial ID
NCT03960060
Treatments Being Tested
This is a prospective study comparing autologous hematopoietic stem cell tr...
Status
Not Yet Recruiting
Location
The Affiliated Hospital oh Xuzhou Medical University
Start Date
2025-05-01
Trial ID
NCT06963866
Treatments Being Tested
An evaluation of LY007 cell injection for recurrent/refractory CD20 was pos...
Status
Unknown
Location
Ruijin hospital
Start Date
2021-12-25
Trial ID
NCT06364852
Treatments Being Tested
The purpose of this study is to assess the feasibility, safety and efficacy...
Status
Terminated
Location
Shenzhen Geno-immune Medical Institute
Start Date
2025-09-01
Trial ID
NCT07193966
Treatments Being Tested
Chimeric antigen receptor T cells (car-t) is one of the most effective ther...
Status
Completed
Location
No.3, Qingchun East Road
Start Date
2018-10-11
Trial ID
NCT04650724
Treatments Being Tested
Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Status
Unknown
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2016-03
Trial ID
NCT02715362
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of QEL...
Status
Active Not Recruiting
Location
H. Saint Luc
Start Date
2022-01-21
Trial ID
NCT05234190
Treatments Being Tested
This study is a single-center, open-label, dose-exploration trial designed ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07185490
Treatments Being Tested